Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.65) by 4.62 percent. This is a 134.25 percent decrease over earnings of $1.81 per share from the same period last year.
Infinera Q2 EPS $(0.05) Beats $(0.08) Estimate, Sales $358.00M Beat $351.05M Estimate
Infinera (NASDAQ:INFN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.08) by 37.5 percent. This is a 66.67 percent decrease over losses of $(0.03) per share from the same
